|
| Press Releases |
|
 |
|
| Thursday, March 12, 2026 |
|
|
OrbusNeich Achieves Record-breaking Revenue, Sales Volume and Gross Profit in FY2025, Net Profit Rises to US$42 million, Final Dividend Increases by 20% to HK12 Cents per Share |
| OrbusNeich Medical Group Holdings Limited ('OrbusNeich' or the 'Group'; stock code: 6929), a multinational medical device company specializing in interventional devices for percutaneous coronary intervention ('PCI') and percutaneous transluminal angioplasty ('PTA') procedures, today announced its annual results for the year ended December 31, 2025 ('FY2025' or the 'Year'). more info >> |
|
|
業聚醫療2025財年收入、銷量及毛利齊創新高 純利增至約4,200萬美元 末期股息升兩成至每股12港仙 |
| 專營經皮冠狀動脈介入治療（PCI）及經皮腔內血管成形術（PTA）手術介入器械的全球醫療器械製造公司業聚醫療集團控股有限公司（「業聚醫療」或「集團」；股份代號：6929）今天宣佈截至2025年12月31日止年度（「2025財政年度」或「回顧年」）的全年業績。 more info >> |
|
|
业聚医疗2025财年收入、销量及毛利齐创新高 纯利增至约4,200万美元 末期股息升两成至每股12港仙 |
| 专营经皮冠状动脉介入治疗（PCI）及经皮腔内血管成形术（PTA）手术介入器械的全球医疗器械制造公司业聚医疗集团控股有限公司（"业聚医疗"或"集团"；股份代号：6929）今天宣布截至2025年12月31日止年度（"2025财政年度"或"回顾年"）的全年业绩。 more info >> |
|
| Friday, August 15, 2025 |
|
|
OrbusNeich Records Growth in 2025 Interim Results, Revenue and Net Profit Reach US$83.6 Million and US$19.8 Million Respectively |
| OrbusNeich Medical Group Holdings Limited ('OrbusNeich' or the 'Group'; stock code: 6929), a multinational medical device company specializing in interventional devices for percutaneous coronary intervention ('PCI') and percutaneous transluminal angioplasty ('PTA') procedures, today announced its interim results for the six months ended June 30, 2025 (the 'Period'), reporting growth in both revenue and net profit despite an uncertain macroeconomic landscape. more info >> |
|
|
業聚醫療2025年中期業績收入及純利雙雙增長 分別達8,360萬美元及1,980萬美元 |
| 專營經皮冠狀動脈介入治療（PCI）及經皮腔內血管成形術（PTA）手術介入器械的全球醫療器械製造公司業聚醫療集團控股有限公司（「業聚醫療」或「集團」；股份代號：6929）今天宣佈截至2025年6月30日止六個月(「報告期」)的中期業績。儘管宏觀經濟環境未見明朗，集團的收入及純利仍雙雙錄得增長。 more info >> |
|
|
业聚医疗2025年中期业绩收入及纯利双双增长 分别达8,360万美元及1,980万美元 |
| 专营经皮冠状动脉介入治疗（PCI）及经皮腔内血管成形术（PTA）手术介入器械的全球医疗器械制造公司业聚医疗集团控股有限公司（"业聚医疗"或"集团"；股份代号：6929）今天宣布截至2025年6月30日止六个月("报告期")的中期业绩。尽管宏观经济环境未见明朗，集团的收入及纯利仍双双录得增长。 more info >> |
|
| Friday, March 7, 2025 |
|
|
OrbusNeich Achieves Fourth Consecutive Year of Revenue Growth with Record High Revenue of US$164.1 Million and Net Profit of US$39.7 Million |
| OrbusNeich Medical Group Holdings Limited ('OrbusNeich' or the 'Group'; stock code: 6929), a major global medical device manufacturer specializing in interventional devices for percutaneous coronary intervention ('PCI') and percutaneous transluminal angioplasty ('PTA') procedures, today announced its annual results for the year ended December 31, 2024 (the 'Year'), reporting record-high revenue and healthy net profit despite the challenging business landscape. more info >> |
|
|
業聚醫療連續四年實現收入增長 達1.64億美元創新高 純利達3,970萬美元 建議派發末期股息每股10港仙 |
| 專營經皮冠狀動脈介入治療（PCI）及經皮腔內血管成形術（PTA）手術介入器械的全球主要醫療器械製造商業聚醫療集團控股有限公司（「業聚醫療」或「集團」；股份代號：6929）今天宣佈截至截至2024年12月31日止年度（「年度」）的全年業績。 more info >> |
|
|
业聚医疗连续四年实现收入增长 达1.64亿美元创新高 纯利达3,970万美元 建议派发末期股息每股10港仙 |
| 专营经皮冠状动脉介入治疗（PCI）及经皮腔内血管成形术（PTA）手术介入器械的全球主要医疗器械制造商业聚医疗集团控股有限公司（“业聚医疗”或“集团”；股份代号：6929）今天宣布截至截至2024年12月31日止年度（“年度”）的全年业绩。 more info >> |
|
| Friday, August 16, 2024 |
|
|
OrbusNeich Records Net Profit of US$18.8 Million for the First Half of 2024 |
| OrbusNeich Medical Group Holdings Limited ('OrbusNeich' or the 'Group'; stock code: 6929), a major global medical device manufacturer specializing in interventional devices for percutaneous coronary intervention ('PCI') and percutaneous transluminal angioplasty ('PTA') procedures, today announced its interim results for the six months ended June 30, 2024 (the 'Reporting Period), with revenue and profit for the period attributable to owners of the Company maintained at US$78.9 million and US$18.8 million respectively despite various market challenges. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
エーザイ、米国臨床腫瘍学会年次総会（ASCO）において、「レンビマ(R)」（レンバチニブ）の承認済み適応症に関する臨床エビデンスを補強する最新データを発表
May 21, 2026 16:45: JST
|
|
|
三菱重工、防衛省向け3,900トン型護衛艦「なとり」を長崎にて引渡し
May 21, 2026 15:00: JST
|
|
|
東森集團全面擁抱AI 東森自然美與百度啟動戰略合作
May 21, 2026 14:21 HKT/SGT
|
|
|
Honda、小型EV「Super-ONE」を発売
May 21, 2026 13:00: JST
|
|
|
Fujitsu supports the Panasonic Group in accelerating its sustainability management through the implementation of a CFP calculation solution
May 21, 2026 13:57 JST
|
|
|
Sharp Launches Poketomo Conversational AI Character in Taiwan
May 21, 2026 13:55 JST
|
|
|
Hitachi Energy's HMAX Energy service solutions strengthen long-term reliability for Akaysha Energy's Ulinda Park BESS
May 21, 2026 13:40 JST
|
|
|
CNNオリジナルシリーズ「K-Everything」 ダニエル・デイ・キムが韓国の食文化を探訪
May 21, 2026 12:00: JST
|
|
|
富士通、パナソニックグループに製品カーボンフットプリント算定ソリューションを導入し、サステナビリティ経営の加速を支援
May 21, 2026 10:45: JST
|
|
|
The 13th PropertyGuru Asia Awards Malaysia with iProperty enters final call with new lead legal advisor
May 21, 2026 10:30 HKT/SGT
|
|
|
Tradelink and PAA Digital Trade Alliance, Co-Organise the 'Global Digital Trade Symposium 2026 - The Hong Kong Experience'
May 20, 2026 20:06 HKT/SGT
|
|
|
贸易通与PAA数位贸易联盟 携手举办"2026年全球数码贸易研讨会 - 香港体验"
May 20, 2026 20:06 HKT/SGT
|
|
|
貿易通與PAA數位貿易聯盟 攜手舉辦「2026年全球數碼貿易研討會 - 香港體驗」
May 20, 2026 20:06 HKT/SGT
|
|
|
Leading UK School Group to Establish Phuket Campus as International School Demand Grows Beyond Bangkok
May 20, 2026 19:00 HKT/SGT
|
|
|
Doubleview Commences Advanced 2026 Exploration and Technical Program at the Hat Polymetallic Project
May 20, 2026 17:59 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
